Contemporary Mortality Differences Between Primary Percutaneous Coronary Intervention and Thrombolysis in ST-Segment Elevation Myocardial Infarction

被引:0
|
作者
Claeys, Marc J. [1 ]
de Meester, Antoine [2 ]
Convens, Carl [3 ]
Dubois, Philippe [4 ]
Boland, Jean [5 ]
De Raedt, Herbert [6 ]
Vranckx, Pascal [7 ]
Coussement, Patrick [8 ]
Gevaert, Sofie [9 ]
Sinnaeve, Peter [10 ]
Evrard, Patrick [11 ]
Beauloye, Christophe [12 ]
Renard, Marc [13 ]
Vrints, Christiaan [1 ]
机构
[1] Univ Antwerp Hosp, Dept Cardiol, B-2650 Edegem, Belgium
[2] Hop Jolimont, Dept Cardiol, Haine St Paul, Belgium
[3] Ziekenhuis Netwerk Antwerpen, Dept Cardiol, Antwerp, Belgium
[4] Ctr Hosp Univ Charleroi, Dept Cardiol, Charleroi, Belgium
[5] Ctr Hosp Reg Citadelle Liege, Dept Cardiol, Liege, Belgium
[6] Onze Lieve Vrouwziekenhuis Ziekenhuis Aalst, Dept Cardiol, Aalst, Belgium
[7] Virga Jesse Ziekenhuis, Dept Cardiol, Hasselt, Belgium
[8] AZ Sint Jan Brugge, Dept Cardiol, Brugge, Belgium
[9] Univ Ziekenhuis Gent, Dept Cardiol, Ghent, Belgium
[10] Univ Ziekenhuis Leuven, Dept Cardiol, Leuven, Belgium
[11] UCL Mt Godinne, Dept Cardiol, Yvoir, Belgium
[12] UCL Louvain, Dept Cardiol, Louvain, Belgium
[13] Univ Libre Bruxelles, Brussels, Belgium
关键词
TIMI RISK SCORE; PRIMARY ANGIOPLASTY; IMMEDIATE ANGIOPLASTY; REPERFUSION THERAPY; HOSPITAL MORTALITY; NATIONAL REGISTRY; LONG; MANAGEMENT; TRIAL; FIBRINOLYSIS;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Current ST-segment elevation myocardial infarction guidelines regarding reperfusion strategy are based on trials conducted before the application of routine invasive evaluation after thrombolysis. Modern thrombolysis may affect the previously observed mortality difference between primary percutaneous coronary intervention (PPCI) and thrombolysis. Methods: In-hospital mortality was prospectively assessed in 5295 patients with ST-segment elevation myocardial infarction admitted to 73 Belgian hospitals from July 1, 2007, through December 31, 2009. A total of 4574 patients (86.4%) were treated with PPCI and 721 (13.6%) received thrombolysis; of these thrombolysis patients, 603 (83.6%) underwent subsequent invasive evaluation. The Thrombolysis in Myocardial Infarction risk score was used to stratify the study population by low (n = 1934), intermediate (n = 2382), and high (n = 979) risk. Results: In-hospital mortality in the PPCI patients was 5.9% vs 6.6% in the thrombolysis patients. After adjustment for differences in baseline risk profile, a significant mortality benefit was only present in the high-risk groups: 23.7% in the PPCI patients vs 30.6% in the thrombolysis patients. For patients not at high risk, the mortality difference was marginal. For low-risk patients, mortality was 0.3% in the PPCI patients vs 0.4% in the thrombolysis patients. For intermediate-risk patients, mortality was 2.9% in the PPCI patients vs 3.1% in the thrombolysis patients. Subgroup analysis revealed that the mortality benefit of PPCI compared with early thrombolysis (door-to-needle time <30 minutes) was offset if the door-to-balloon time exceeded 60 minutes. Conclusions: Modern thrombolytic strategies have substantially attenuated the absolute mortality benefit of PPCI over thrombolysis, particularly in patients not at high risk. Our study findings suggest that target door-to-balloon time should be less than 60 minutes to maintain the lowest mortality rates.
引用
收藏
页码:544 / 549
页数:6
相关论文
共 50 条
  • [21] Impact of renal insufficiency on mortality in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention
    Jonas Emil Sabroe
    Per Thayssen
    Lisbeth Antonsen
    Mikkel Hougaard
    Knud Nørregaard Hansen
    Lisette Okkels Jensen
    BMC Cardiovascular Disorders, 14
  • [22] Impact of renal insufficiency on mortality in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention
    Sabroe, Jonas Emil
    Thayssen, Per
    Antonsen, Lisbeth
    Hougaard, Mikkel
    Hansen, Knud Norregaard
    Jensen, Lisette Okkels
    BMC CARDIOVASCULAR DISORDERS, 2014, 14
  • [23] Sex differences in time to primary percutaneous coronary intervention and outcomes in patients presenting with ST-segment elevation myocardial infarction
    Savage, Michael L.
    Hay, Karen
    Murdoch, Dale J.
    Walters, Darren L.
    Denman, Russell
    Ranasinghe, Isuru
    Raffel, Christopher
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2022, 100 (04) : 520 - 529
  • [24] Comparison of the cost in percutaneous coronary intervention between ST-segment elevation myocardial infarction vs. non-ST-segment elevation myocardial infarction
    Tsukasa Murakami
    Kenichi Sakakura
    Yousuke Taniguchi
    Kei Yamamoto
    Takunori Tsukui
    Masaru Seguchi
    Hiroyuki Jinnouchi
    Hiroshi Wada
    Hideo Fujita
    Cardiovascular Intervention and Therapeutics, 2022, 37 : 293 - 303
  • [25] Comparison of the cost in percutaneous coronary intervention between ST-segment elevation myocardial infarction vs. non-ST-segment elevation myocardial infarction
    Murakami, Tsukasa
    Sakakura, Kenichi
    Taniguchi, Yousuke
    Yamamoto, Kei
    Tsukui, Takunori
    Seguchi, Masaru
    Jinnouchi, Hiroyuki
    Wada, Hiroshi
    Fujita, Hideo
    CARDIOVASCULAR INTERVENTION AND THERAPEUTICS, 2022, 37 (02) : 293 - 303
  • [26] The relationship between Gensini score and ST-segment resolution in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention
    Zencirci, Aycan Esen
    Zencirci, Ertugrul
    Degirmencioglu, Aleks
    Karakus, Gultekin
    Ugurlucan, Murat
    Gunduz, Sabahattin
    Ozden, Kivilcim
    Erdem, Aysun
    Karadeniz, Fatma
    Ekmekci, Ahmet
    Erer, Hatice
    Sayar, Nurten
    Eren, Mehmet
    KARDIOLOGIA POLSKA, 2014, 72 (06) : 494 - 503
  • [27] Transradial Versus Transfemoral Primary Percutaneous Coronary Intervention for Acute ST-Segment Elevation Myocardial Infarction
    Nah, Deuk-Young
    Bae, Jun-Ho
    Chung, Jin Wook
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 65 (17) : S63 - S63
  • [28] Alternative stents in ST-segment elevation myocardial infarction: improving the efficacy of primary percutaneous coronary intervention
    Yetgin, Tuncay
    Nakatani, Shimpei
    Onuma, Yoshinobu
    van Geuns, Robert-Jan M.
    FUTURE CARDIOLOGY, 2015, 11 (03) : 347 - 357
  • [29] Primary Percutaneous Coronary Intervention as a National Reperfusion Strategy in Patients With ST-Segment Elevation Myocardial Infarction
    Terkelsen, Christian J.
    Jensen, Lisette O.
    Tilsted, Hans H.
    Thaysen, Per
    Ravkilde, Jan
    Johnsen, Soren P.
    Trautner, Sven
    Andersen, Henning R.
    Thuesen, Leif
    Lassen, Jens F.
    CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2011, 4 (06) : 570 - 576
  • [30] Iron deficiency in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention
    Cosentino, Nicola
    Campodonico, Jeness
    Pontone, Gianluca
    Guglielmo, Marco
    Trinei, Mirella
    Sandri, Maria Teresa
    Riggio, Daniela
    Baggiano, Andrea
    Milazzo, Valentina
    Moltrasio, Marco
    Muscogiuri, Giuseppe
    Bonomi, Alice
    Barbieri, Simone
    Assanelli, Emilio
    Lauri, Gianfranco
    Bartorelli, Antonio
    Marenzi, Giancarlo
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2020, 300 : 14 - 19